Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
Elizabeth Fraley, Cas LeMaster, Eric S. Geanes, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: A systematic review
Kin Israel Notarte, Israel Guerrero‐Arguero, Jacqueline Veronica Velasco, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2939-2961
Open Access | Times Cited: 116
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review
Kin Israel Notarte, Abbygail Therese Ver, Jacqueline Veronica Velasco, et al.
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 59, Iss. 6, pp. 373-390
Open Access | Times Cited: 88
Exercise after influenza or COVID-19 vaccination increases serum antibody without an increase in side effects
Justus E. Hallam, Tyanez Jones, Jessica Alley, et al.
Brain Behavior and Immunity (2022) Vol. 102, pp. 1-10
Open Access | Times Cited: 52
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine
Kevin J. Kramer, Erin M. Wilfong, Kelsey Voss, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Current view on novel vaccine technologies to combat human infectious diseases
Zrinka Matić, Maja Šantak
Applied Microbiology and Biotechnology (2021) Vol. 106, Iss. 1, pp. 25-56
Open Access | Times Cited: 53
Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response
Jesús Ontañón, Joaquín Blas, Carlos de Cabo, et al.
EBioMedicine (2021) Vol. 73, pp. 103656-103656
Open Access | Times Cited: 41
Neutralizing Activity and SARS-CoV-2 Vaccine mRNA Persistence in Serum and Breastmilk After BNT162b2 Vaccination in Lactating Women
Kee Thai Yeo, Wan Ni Chia, Chee Wah Tan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 35
Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination
Eric S. Geanes, Cas LeMaster, Elizabeth Fraley, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 33
Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccine
Lauren Myburgh, Haiko Karsjens, Athanasios Blanas, et al.
Vaccine (2025) Vol. 54, pp. 126989-126989
Open Access
Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination
Daniel Grupel, Sivan Gazit, Licita Schreiber, et al.
Vaccine (2021) Vol. 39, Iss. 38, pp. 5337-5340
Open Access | Times Cited: 36
Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study
Baharak Babouee Flury, Sabine Güsewell, Thomas Egger, et al.
PLoS Medicine (2022) Vol. 19, Iss. 11, pp. e1004125-e1004125
Open Access | Times Cited: 23
The kinetics of IgG subclasses and contributions to neutralizing activity against SARS‐CoV‐2 wild‐type strain and variants in healthy adults immunized with inactivated vaccine
Weixin Chen, Lichi Zhang, Juan Li, et al.
Immunology (2022) Vol. 167, Iss. 2, pp. 221-232
Open Access | Times Cited: 19
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants
Marc Emmenegger, Sebastian Fiedler, Silvio D. Brugger, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104766-104766
Open Access | Times Cited: 19
Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
Marina Saresella, Federica Piancone, Ivana Marventano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
The Effect of Waning on Antibody Levels and Memory B Cell Recall following SARS-CoV-2 Infection or Vaccination
David Forgacs, Vanessa Silva‐Moraes, Giuseppe A. Sautto, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 696-696
Open Access | Times Cited: 15
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies
Maryam Noori, Shadi Azizi, Farhan Abbasi Varaki, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109046-109046
Open Access | Times Cited: 14
DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study
Kaoru Toyama, Takashi Eto, Kenji Takazawa, et al.
Vaccine (2023) Vol. 41, Iss. 38, pp. 5525-5534
Open Access | Times Cited: 8
The Impact of Prior Infection and Age on Antibody Persistence After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine
Elizabeth Fraley, Cas LeMaster, Santosh Khanal, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e902-e904
Open Access | Times Cited: 18
Humoral and cellular response to the COVID-19 vaccine in immunocompromised children
Heather A. Morgans, Todd Bradley, Linda Flebbe-Rehwaldt, et al.
Pediatric Research (2022) Vol. 94, Iss. 1, pp. 200-205
Open Access | Times Cited: 12
Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review
Kin Israel Notarte, Israel Guerrero‐Arguero, Jacqueline Veronica Velasco, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 16
Vaccine-associated corneal graft rejection following SARS-CoV-2 vaccination: a CDC-VAERS database analysis
Rohan Bir Singh, Jeffrey Li, Uday Pratap Singh Parmar, et al.
British Journal of Ophthalmology (2022) Vol. 108, Iss. 1, pp. 17-22
Open Access | Times Cited: 11
Immunogenicity and safety of the BBIBP‐CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort
Batool Zamani, Amin Moradi Hasan‐Abad, Ahmad Piroozmand, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 6
Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand
Prapassorn Poolchanuan, Wasin Matsee, Sineenart Sengyee, et al.
mSphere (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 5
210-Day Kinetics of Total, IgG, and Neutralizing Spike Antibodies across a Course of 3 Doses of BNT162b2 mRNA Vaccine
Chin Shern Lau, May Lin Helen Oh, Soon Kieng Phua, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1703-1703
Open Access | Times Cited: 9
Effects of Age, Sex, Serostatus and Underlying Comorbidities on Humoral Response Post-SARS-CoV-2 Pfizer-BioNTech Vaccination – A Systematic Review
Kin Israel Notarte, Abbygail Therese Ver, Jacqueline Veronica Velasco, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top